Discover open access scientific publications

Search, annotate, share and cite publications

Publications by D. Kozono

P3.17-12 Phase II Trial of Atezolizumab Before and After Chemoradiation for Unresectable Stage III NSCLC (AFT-16): Trial in Progress

Journal of Thoracic Oncology

English

From the Cover: Conversion of Aquaporin 6 From an Anion Channel to a Water-Selective Channel by a Single Amino Acid Substitution

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

2005

English

Related publications

OA01.07 Updated Results of a Phase II Trial of Concurrent Chemoradiation With Consolidation Pembrolizumab in Patients With Unresectable Stage III NSCLC

Journal of Thoracic Oncology

English

MA05.01 E6508: Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Unresectable Stage III NS-NSCLC

Journal of Thoracic Oncology

English

Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated After Chemoradiotherapy and an 8-Year Update on a Phase I/Ii Trial

Clinical Cancer Research

Cancer Research

Oncology

2011

English

P1.01-88 Osimertinib Maintenance After Definitive Chemoradiation in Patients With Unresectable EGFRm-Positive Stage III NSCLC (LAURA)

Journal of Thoracic Oncology

English

P2.17-27 IMpower030: Phase III Study Evaluating Neoadjuvant Treatment of Resectable Stage II-IIIB NSCLC With Atezolizumab + Chemotherapy

Journal of Thoracic Oncology

English

OA01.06 DETERRED: Phase II Trial Combining Atezolizumab Concurrently With Chemoradiation Therapy in Locally Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

Randomized Phase III Trial Comparing Surgery Alone to UFT + PSK for Stage II Rectal Cancer (JFMC38 Trial)

Cancer Chemotherapy and Pharmacology

English

Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months

Journal of Thoracic Oncology

English

Phase 2 Trial of Neoadjuvant Bevacizumab Plus Pemetrexed and Carboplatin in Patients With Unresectable Stage III Lung Adenocarcinoma (GASTO 1001)

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by D. Kozono

P3.17-12 Phase II Trial of Atezolizumab Before and After Chemoradiation for Unresectable Stage III NSCLC (AFT-16): Trial in Progress

From the Cover: Conversion of Aquaporin 6 From an Anion Channel to a Water-Selective Channel by a Single Amino Acid Substitution

Related publications

OA01.07 Updated Results of a Phase II Trial of Concurrent Chemoradiation With Consolidation Pembrolizumab in Patients With Unresectable Stage III NSCLC

MA05.01 E6508: Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Unresectable Stage III NS-NSCLC

Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated After Chemoradiotherapy and an 8-Year Update on a Phase I/Ii Trial

P1.01-88 Osimertinib Maintenance After Definitive Chemoradiation in Patients With Unresectable EGFRm-Positive Stage III NSCLC (LAURA)

P2.17-27 IMpower030: Phase III Study Evaluating Neoadjuvant Treatment of Resectable Stage II-IIIB NSCLC With Atezolizumab + Chemotherapy

OA01.06 DETERRED: Phase II Trial Combining Atezolizumab Concurrently With Chemoradiation Therapy in Locally Advanced Non-Small Cell Lung Cancer

Randomized Phase III Trial Comparing Surgery Alone to UFT + PSK for Stage II Rectal Cancer (JFMC38 Trial)

Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months

Phase 2 Trial of Neoadjuvant Bevacizumab Plus Pemetrexed and Carboplatin in Patients With Unresectable Stage III Lung Adenocarcinoma (GASTO 1001)